It’s no secret that diagnostics companies around the globe have benefited from the COVID pandemic by supplying testing equipment and other related products. South Korean companies are no exception - in fact, they have fared even better than many of their international peers. And, having generated unprecedented revenues, many are now looking to take advantage of their cash position by seeking strategic partnerships and investments in the west.